Shuttle Pharmaceuticals Inc (SHPH)

NASDAQ
1.45
-0.05(-3.33%)
Pre Market
1.50
+0.05(+3.45%)
- Real-time Data
  • Volume:
    96,285
  • Day's Range:
    1.42 - 1.51
  • 52 wk Range:
    1.42 - 126.26
Trading near 52-week Low

Shuttle Pharmaceuticals has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

SHPH Overview

Prev. Close
1.5
Day's Range
1.42-1.51
Revenue
-
Open
1.49
52 wk Range
1.42-126.26
EPS
-0.295
Volume
96,285
Market Cap
23.54M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,210,919
P/E Ratio
-5.94
Beta
-
1-Year Change
-
Shares Outstanding
11,948,650
Next Earnings Date
-
What is your sentiment on Shuttle Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Shuttle Pharmaceuticals Inc News

  • Shuttle Pharmaceuticals IPO Opens Sharply Higher
    • ByInvesting.com-

    Today's IPO for Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) opened for trading at $24.05 after pricing 1,225,888 units of common stock and warrants, which priced at...

Shuttle Pharmaceuticals Inc Company Profile

Shuttle Pharmaceuticals Inc Company Profile

Employees
5

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellSell
Technical IndicatorsBuySellStrong SellStrong SellSell
SummaryNeutralStrong SellStrong SellStrong SellSell